Creative Biolabs provides one-step growth curve of phage service for research teams that need to measure phage replication dynamics on a selected bacterial host. The workflow supports synchronized infection setup, serial timepoint sampling, phage titer measurement, curve plotting, and reporting of key parameters such as latent period and burst size under defined conditions.
A one-step growth curve is most useful when the project needs more than a final titer. It explains how quickly phage progeny appear, when the rise phase occurs, and how the tested host-condition pair shapes apparent burst behavior. We design the assay so the curve is interpretable and the limitations are clear.
This assay is appropriate when a phage has already shown activity against a host and the next question is about replication timing. It is commonly used to support phage characterization, compare candidate phages, select conditions for follow-up assays, or document biological properties before formulation or engineering research.
Estimate the interval before newly produced phages are detected.
Track when extracellular phage numbers increase after synchronized infection.
Calculate approximate progeny output per infected cell under tested conditions.
Compare selected host-growth or medium conditions when the design supports it.
One-step growth analysis depends on controlled infection synchronization. We define the host growth phase, selected MOI, adsorption window, dilution or anti-phage serum strategy when suitable, sampling interval, plating method, and calculation rules before the experiment begins. Useful original parameters, including host growth curve, phage lysate titer, latent period, lysis/rise phase, stationary phase, and burst size, are retained in the workplan.
Host cells are prepared at the agreed growth phase to support synchronized infection.
Phage and host are combined at the selected MOI and adsorption interval.
Dilution, washing, or neutralization strategy is applied when suitable for the system.
Samples are collected across the latent, rise, and stationary phases.
Phage titers are measured with a compatible plating or enumeration method.
The curve, raw counts, latent period, and burst size are reported with method notes.
| Input | Purpose |
|---|---|
| Phage stock and sensitive host strain | Defines the phage-host pair for the curve. |
| Host growth curve or target growth phase | Supports reproducible infection timing. |
| Target MOI or prior MOI data | Helps choose an adsorption setup that avoids avoidable noise. |
| Sampling schedule and plating preference | Controls data density and countability. |
Creative Biolabs typically returns a time-resolved titer table, plotted one-step growth curve, latent-period estimate, rise/lysis-phase annotation, stationary-phase notes, burst-size calculation, raw plate-count data, and interpretation notes for the tested host-condition pair.
QC planning includes host growth-stage consistency, adsorption timing, dilution accuracy, countable plate criteria, replicate agreement, and timepoint integrity. If the data do not clearly separate latent and rise phases, the report will describe that limitation rather than forcing an overprecise parameter estimate.
The assay can be adjusted around adsorption setup, synchronization method, sampling interval, dilution or serum-treatment approach, plating method, replicate plan, and the level of parameter reporting. We can also align the design with MOI determination or host-range testing when those data are not yet available.
Ready to plan the next experiment? Send us the host/phage information you already have, and we will help define a research-use workflow, data package, and reporting scope that fit your project.
Recent phage characterization studies continue to use one-step growth analysis to describe replication behavior, including latent period, rise phase, and burst size under a defined host-condition pair. In a 2026 study on lytic bacteriophages against multidrug-resistant Escherichia coli, the authors combined isolation, genomic characterization, MOI-related testing, and one-step growth curve analysis to describe phage behavior before evaluating application potential in vitro. The study shows how one-step growth curves fit within a broader characterization package. But it does not imply that parameters measured in one host system can be transferred to another phage, host, medium, or application setting.
Fig.1 Published in vitro characterization of E. coli phages Sem1, Sem2, Sem3, and Sem4, including plaque morphology, TEM imaging, one-step growth curves, and MOI-dependent growth inhibition. 1
Q: What information is needed to start a One-step Growth Curve of Phage project?
A: We usually need the phage stock, sensitive host strain, target growth phase, selected MOI or prior MOI information, sampling schedule, and preferred titer method.
Q: Can the One-step Growth Curve workflow be customized?
A: Yes. We can adjust adsorption setup, synchronization strategy, timepoint density, plating method, replicate plan, and reporting format for latent period, rise phase, stationary phase, and burst size.
Q: What deliverables are included?
A: We typically provide a growth curve chart, time-resolved titer table, latent period estimate, burst size calculation, raw count data, and method notes.
Q: How are quality checks handled?
A: We review host growth stage, adsorption timing, dilution accuracy, countable plate criteria, replicate consistency, and timepoint integrity. Ambiguous curves are reported with their limitations.
Q: Can one-step growth parameters be compared across phages?
A: Yes, if the design uses comparable hosts, growth phases, MOI, sampling intervals, and enumeration methods. Otherwise, comparisons should be treated as exploratory.
Q: How can I discuss a nonstandard curve design?
A: Send your phage-host pair, growth condition, proposed timepoints, and project goal. We will help define a curve design with enough resolution for interpretation.
Reference:
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
